PLI SCHEME FOR PROMOTION OF DOMESTIC MANUFACTURING OF CRITICAL KSMS/ DRUG INTERMEDIATES AND APIs

April 14, 2021

Approvals have been accorded to 16 applicants under Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country.

About:

The setting up of these 16 plants will lead to total committed investment of Rs.348.70 crore and employment generation of about 3,042 by the companies.
The commercial production of these plants is projected to commence from 1st April, 2023 onward.
The scheme has been launched by the Department of Pharmaceuticals for promotion of domestic manufacturing of KSMs/APIs.
This will be achieved by setting up greenfield plants with minimum domestic value addition in four different Target Segments (In Two Fermentation based - at least 90% and in the Two Chemical Synthesis based – at least 70% ) for 41 products with a total outlay of Rs. 6,940 cr. for the period 2020-21 to 2029-30.

Source : PIB